Finley John David
Palisade Bio, Inc. · CEO
Finley John David is listed in filings as CEO at Palisade Bio, Inc.. This profile follows SEC Form 4 activity through Feb 13, 2026, including sale activity. Recent filings connect the profile to Palisade Bio, Inc. (PALI). The current snapshot covers public activity from Feb 13, 2025 to Feb 13, 2026. Reported amounts are shown as $6.8K to $53.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $6.8k3.9k shares | SellFeb 12, 2026 | $1.75 | $1.97 |